Cargando…
贝林妥欧单抗治疗复发难治急性淋巴细胞白血病13例疗效及不良反应分析
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450561/ https://www.ncbi.nlm.nih.gov/pubmed/37550212 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.06.015 |
| _version_ | 1785095229696638976 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10450561 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Editorial office of Chinese Journal of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104505612023-08-26 贝林妥欧单抗治疗复发难治急性淋巴细胞白血病13例疗效及不良反应分析 Zhonghua Xue Ye Xue Za Zhi 短篇论著 Editorial office of Chinese Journal of Hematology 2023-06 /pmc/articles/PMC10450561/ /pubmed/37550212 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.06.015 Text en 2023年版权归中华医学会所有 https://creativecommons.org/licenses/by/3.0/This work is licensed under a Creative Commons Attribution 3.0 License. |
| spellingShingle | 短篇论著 贝林妥欧单抗治疗复发难治急性淋巴细胞白血病13例疗效及不良反应分析 |
| title | 贝林妥欧单抗治疗复发难治急性淋巴细胞白血病13例疗效及不良反应分析 |
| title_full | 贝林妥欧单抗治疗复发难治急性淋巴细胞白血病13例疗效及不良反应分析 |
| title_fullStr | 贝林妥欧单抗治疗复发难治急性淋巴细胞白血病13例疗效及不良反应分析 |
| title_full_unstemmed | 贝林妥欧单抗治疗复发难治急性淋巴细胞白血病13例疗效及不良反应分析 |
| title_short | 贝林妥欧单抗治疗复发难治急性淋巴细胞白血病13例疗效及不良反应分析 |
| title_sort | 贝林妥欧单抗治疗复发难治急性淋巴细胞白血病13例疗效及不良反应分析 |
| topic | 短篇论著 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10450561/ https://www.ncbi.nlm.nih.gov/pubmed/37550212 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2023.06.015 |
| work_keys_str_mv | AT bèilíntuǒōudānkàngzhìliáofùfānánzhìjíxìnglínbāxìbāobáixuèbìng13lìliáoxiàojíbùliángfǎnyīngfēnxī AT bèilíntuǒōudānkàngzhìliáofùfānánzhìjíxìnglínbāxìbāobáixuèbìng13lìliáoxiàojíbùliángfǎnyīngfēnxī AT bèilíntuǒōudānkàngzhìliáofùfānánzhìjíxìnglínbāxìbāobáixuèbìng13lìliáoxiàojíbùliángfǎnyīngfēnxī AT bèilíntuǒōudānkàngzhìliáofùfānánzhìjíxìnglínbāxìbāobáixuèbìng13lìliáoxiàojíbùliángfǎnyīngfēnxī AT bèilíntuǒōudānkàngzhìliáofùfānánzhìjíxìnglínbāxìbāobáixuèbìng13lìliáoxiàojíbùliángfǎnyīngfēnxī AT bèilíntuǒōudānkàngzhìliáofùfānánzhìjíxìnglínbāxìbāobáixuèbìng13lìliáoxiàojíbùliángfǎnyīngfēnxī AT bèilíntuǒōudānkàngzhìliáofùfānánzhìjíxìnglínbāxìbāobáixuèbìng13lìliáoxiàojíbùliángfǎnyīngfēnxī AT bèilíntuǒōudānkàngzhìliáofùfānánzhìjíxìnglínbāxìbāobáixuèbìng13lìliáoxiàojíbùliángfǎnyīngfēnxī |